AI Article Synopsis
- COVID-19 seems to affect men more severely than women, potentially due to genetic differences, particularly in the androgen receptor (AR) gene.
- Researchers analyzed data from severely ill COVID-19 patients and found that shorter variations of the polyQ segment in the AR gene were linked to better outcomes, while longer polyQ variants were associated with severe disease in different male cohorts.
- The study suggests that low testosterone levels in men with long polyQ variants may lead to worse clinical outcomes and highlights the potential for testosterone treatment as a therapeutic option for these patients.
Article Abstract
Background: While SARS-CoV-2 similarly infects men and women, COVID-19 outcome is less favorable in men. Variability in COVID-19 severity may be explained by differences in the host genome.
Methods: We compared poly-amino acids variability from WES data in severely affected COVID-19 patients versus SARS-CoV-2 PCR-positive oligo-asymptomatic subjects.
Findings: Shorter polyQ alleles (≤22) in the androgen receptor (AR) conferred protection against severe outcome in COVID-19 in the first tested cohort (both males and females) of 638 Italian subjects. The association between long polyQ alleles (≥23) and severe clinical outcome (p = 0.024) was also validated in an independent cohort of Spanish men <60 years of age (p = 0.014). Testosterone was higher in subjects with AR long-polyQ, possibly indicating receptor resistance (p = 0.042 Mann-Whitney U test). Inappropriately low serum testosterone level among carriers of the long-polyQ alleles (p = 0.0004 Mann-Whitney U test) predicted the need for intensive care in COVID-19 infected men. In agreement with the known anti-inflammatory action of testosterone, patients with long-polyQ and age ≥60 years had increased levels of CRP (p = 0.018, not accounting for multiple testing).
Interpretation: We identify the first genetic polymorphism that appears to predispose some men to develop more severe disease. Failure of the endocrine feedback to overcome AR signaling defects by increasing testosterone levels during the infection leads to the polyQ tract becoming dominant to serum testosterone levels for the clinical outcome. These results may contribute to designing reliable clinical and public health measures and provide a rationale to test testosterone as adjuvant therapy in men with COVID-19 expressing long AR polyQ repeats.
Funding: MIUR project "Dipartimenti di Eccellenza 2018-2020" to Department of Medical Biotechnologies University of Siena, Italy (Italian D.L. n.18 March 17, 2020) and "Bando Ricerca COVID-19 Toscana" project to Azienda Ospedaliero-Universitaria Senese. Private donors for COVID-19 research and charity funds from Intesa San Paolo.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908850 | PMC |
| http://dx.doi.org/10.1016/j.ebiom.2021.103246 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Role of Med15 Sequence Features in Transcription Factor Interactions.
Mol Cell Biol
December 2024
Department of Biology, University of Iowa, Iowa City, Iowa, USA.
Med15 is a general transcriptional regulator and tail module subunit within the RNA Pol II mediator complex. The Med15 protein has a well-structured N-terminal KIX domain, three activator binding domains (ABDs) and several naturally variable polyglutamine (poly-Q) tracts (Q1, Q2, Q3) embedded in an intrinsically disordered central region, and a C-terminal mediator association domain (MAD). We investigated how the presence of ABDs and changes in length and composition of poly-Q tracts influences Med15 activity using phenotypic, gene expression, transcription factor interaction and phase separation assays of truncation, deletion, and synthetic alleles.
View Article and Find Full Text PDFMutant huntingtin protein decreases with CAG repeat expansion: implications for therapeutics and bioassays.
Brain Commun
November 2024
Department of Neurodegenerative Disease, Huntington's Disease Centre, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
Huntington's disease is an inherited neurodegenerative disorder caused by a CAG repeat expansion that encodes a polyglutamine tract in the huntingtin (HTT) protein. The mutant CAG repeat is unstable and expands in specific brain cells and peripheral tissues throughout life. Genes involved in the DNA mismatch repair pathways, known to act on expansion, have been identified as genetic modifiers; therefore, it is the rate of somatic CAG repeat expansion that drives the age of onset and rate of disease progression.
View Article and Find Full Text PDFAge-dependent somatic expansion of the ATXN3 CAG repeat in the blood and buccal swab DNA of individuals with spinocerebellar ataxia type 3/Machado-Joseph disease.
Hum Genet
November 2024
School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.
Article Synopsis
- Spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) is linked to a CAG repeat expansion in the ATXN3 gene, with longer repeats leading to earlier disease onset and increased intergenerational anticipation.
- Researchers used advanced sequencing techniques to analyze the ATXN3 repeat and somatic expansion in individuals from the Azores, finding issues with traditional measurement methods that could affect understanding of clinical outcomes.
- The study indicated that while age and CAG repeat length influence somatic expansion, the age factor was more significant, and a specific single nucleotide variant was associated with the expansion rate, highlighting the potential for using ATXN3 repeat analysis in clinical trials.
Early-onset phenotype in a patient with an intermediate allele and a large SCA1 expansion: a case report.
BMC Neurol
September 2024
Department of Toxicology and Genopathies, UF Neurobiology, CHU Lille, Lille, F-59000, France.
Background: Spinocerebellar ataxia type 1, is a rare neurodegenerative disorder with autosomal dominant inheritance belonging to the polyglutamine diseases. The diagnosis of this disease requires genetic testing that may also include the search for CAT interruption of the CAG repeat tract.
Case Presentation: One 23-years-old patient suffers from a severe ataxia, with early-onset and rapid progression of the disease.
The Diederik cuckoo, , is a small Afrotropical bird in the family Cuculidae. It is taxonomically related to 13 other species within the genus and is migratory in sub-Saharan Africa. It has a unique breeding behaviour of being a brood parasite: Breeding pairs lay their eggs in the nests of a host species and hatchlings expel the eggs of the host species.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!